NEWS | Promethean BioPharma

top of page

Media Coverage

Australia is leading the way in Pain Solutions.

A New landmark clinical trial into the efficacy of medicinal cannabis tablets on mild-to-moderate pain.

Read the full Media Release

Announced as a Channel 7 Network News Report exclusive on 29th November 2023, news of the clinical trial has received significant coverage throughout Australian media outlets:

Canberra Times

Over-the-counter cannabis pain relief on the horizon

Seven News

A world-first cannabis pill is being trialled that could bring relief to millions of people living with chronic pain.

Canberra City News

OVER-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

Daily Mail

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

The Queenslander

Over-the-counter cannabis pain relief on the horizon.

Lithgow Mercury

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

Bendigo Advertiser

Over-the-counter cannabis pain relief on the horizon

Busselton Mail

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

The Irrigator

Over-the-counter cannabis pain relief on the horizon.

The Senior

If approved the cannabis pain relief tablet could be available without prescription.

Illawarra Mercury

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

Shepparton News

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

City News Queanbeyan

Over-the-counter cannabis on the horizon.

INKL

Over-the-counter cannabis on the horizon.

Manning River Times

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

Moree Champion

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

The Young Witness

Over-the-counter cannabis on the horizon..

Goulburn Post

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

South Coast Register

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

Bateman's Bay Post

Over-the-counter cannabis pain relief on the horizon.

The Examiner

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

North West Star

If approved the cannabis pain relief tablet could be available without prescription.

Cessnock Advertiser

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

Daily Advertiser

Over-the-counter cannabis pain relief on the horizon.

Camden Courier

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

Blue Mountains Gazett

Over-the-counter cannabis pain relief on the horizon.

Canowindra News

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

Cootamundra Herald

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

Blayney Chronicle

Over-the-counter cannabis pain relief on the horizon.

Busselton Mail

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

Katherine Times

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

Braidwood Times

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

Junee Southern Cross

Over-the-counter cannabis pain relief on the horizon

Scone Advocate

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

Grenfell Record

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

Armidale Express

If approved the cannabis pain relief tablet could be available without prescription.

Port Stephens Examiner

Over-the-counter cannabis pain relief on the horizon.

Wellington Times

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

The Courier

Over-the-counter cannabis pain relief on the horizon

Crookwell Gazette

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

Western Advocate

If approved the cannabis pain relief tablet could be available without prescription.

Newcastle Herald

Over-the-counter cannabis pain relief on the horizon.

Southern Highland News

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

Macleay Argus

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

Ulladulla Times

Over-the-counter cannabis pain relief on the horizon.

Central Western Daily

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

Muswellbrook Chronicle

Over-the-counter cannabis pain relief on the horizon.

Camden Courier

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

Canowindra News

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

Matiland Mercury

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

Nyngan Observer

Over-the-counter cannabis pain relief on the horizon.

Forbes Advocate

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

Mudgee Guardian

Over-the-counter cannabis pain relief on the horizon.

Eastern Riverina Chronicle

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

Harden Express

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

The Rural

Over-the-counter cannabis pain relief on the horizon.

Ararat Advertiser

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

Port Macquarie News

Over-the-counter cannabis pain relief on the horizon.

Eden Magnet

If approved the cannabis pain relief tablet could be available without prescription.

Bunbury Mail

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

The Examiner

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

Parkes Champion

Over-the-counter cannabis pain relief on the horizon.

Narooma News

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

Merimbula News

If approved the cannabis pain relief tablet could be available without prescription.

Area News

Over-the-counter cannabis pain relief on the horizon.

Yarrawonga Chronicle

Over-the-counter cannabis pain relief could be available in Australia by the end of 2024 if a phase three clinical trial is successful.

Health Times

Promethean BioPharma is currently testing the efficacy and safety of its new medicinal cannabis tablets for mild to moderate pain.

YouTube

Potential Breakthrough: Over-the-Counter Cannabis Pain Relief in Australia by 2024!

Ground

Cannabis pain relief tablets could eventually be used by people who need an over-the-counter alternative to paracetamol and ibuprofen, which can be dangerous in high doses.

Northern Daily Leader

Over-the-counter cannabis pain relief on the horizon.

bottom of page